Moleculin Biotech (MBRX) Other Gross PP&E Adjustments (2016 - 2025)
Moleculin Biotech's Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$314000.0 for Q4 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$314000.0 for Q4 2025, up 25.94% from a year ago — trailing twelve months through Dec 2025 was -$314000.0 (up 25.94% YoY), and the annual figure for FY2025 was -$314000.0, up 25.94%.
- Other Gross PP&E Adjustments for Q4 2025 was -$314000.0 at Moleculin Biotech, up from -$343000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$81000.0 in Q1 2022 to a low of -$547000.0 in Q3 2023.
- The 5-year median for Other Gross PP&E Adjustments is -$389500.0 (2023), against an average of -$350550.0.
- The sharpest move saw Other Gross PP&E Adjustments skyrocketed 71.84% in 2021, then tumbled 370.37% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$107000.0 in 2021, then tumbled by 276.64% to -$403000.0 in 2022, then plummeted by 30.02% to -$524000.0 in 2023, then grew by 19.08% to -$424000.0 in 2024, then grew by 25.94% to -$314000.0 in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$314000.0, -$343000.0, and -$370000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.